US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

BIOARCTIC AB

31.34

-0.9950-3.08%

Volume:495.00

Turnover:15.62K

Market Cap:2.77B

PE:-242.11

High:31.75

Open:31.75

Low:31.34

Close:32.34

52wk High:32.34

52wk Low:12.94

Shares:88.53M

Float Shares:88.53M

Volume Ratio:1.61

T/O Rate:0.00%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.1294

EPS(LYR):0.2584

ROE:71.96%

ROA:46.25%

PB:12.82

PE(LYR):121.30

Loading ...

Overview Company News Filings

High Growth Tech Stocks To Watch In Europe April 2025

Simply Wall St.

The European Commission refers lecanemab decision to Appeal Committee

3 European Growth Stocks With Insider Ownership Seeing Up To 52% Earnings Growth

Simply Wall St.

BioArctic receives Orphan Drug Designation for exidavnemab the US

The Committee for Medicinal Products for Human Use (CHMP) reaffirms positive opinion for Lecanemab in early Alzheimer's disease in the EU

High Insider Owned Growth Stocks With Earnings Up To 69%

Simply Wall St.

BioArctic AB (BRCTF) Q4 2024 Earnings Call Highlights: Strategic Partnerships and Profitability ...

Exploring Three High Growth Tech Stocks For Future Potential

Simply Wall St.

Tikehau Capital And 2 More Stocks That May Be Priced Below Their Estimated Worth

Simply Wall St.

3 Growth Companies Insiders Own With Earnings Growth Up To 51%

Simply Wall St.

FDA approves IV maintenance dosing of Leqembi® (lecanemab-irmb) for the treatment of early Alzheimer's Disease in the US

FDA accepts Biologics License Application for subcutaneous maintenance dosing of Leqembi® (lecanemab-irmb) in the US

High Growth Tech Stocks To Watch In January 2025

Simply Wall St.

Exploring Undervalued Small Caps With Insider Action In December 2024

Simply Wall St.

Top Growth Stocks With Insider Backing In December 2024

Simply Wall St.

3 Stocks That May Be Trading Below Their Estimated Intrinsic Value

Simply Wall St.

Bristol Myers enters $100M PyroGlu-Ass license agreement with BioArctic

High Growth Tech Stocks To Watch This December 2024

Simply Wall St.

3 Undervalued Small Caps With Insider Buying Across Global Markets

Simply Wall St.

Three Stocks Estimated To Be Undervalued In November 2024

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BRCTF/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BRCTF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BRCTF\",,,,,undefined,":{"symbol":"BRCTF","market":"US","secType":"STK","nameCN":"BIOARCTIC AB","latestPrice":31.34,"timestamp":1756497600000,"preClose":32.335,"halted":0,"volume":495,"delay":15,"floatShares":88531500,"shares":88531500,"eps":-0.129444,"marketStatus":"Closed Labor Day","change":-0.995,"latestTime":"08-29 16:00:00 EDT Delay","open":31.75,"high":31.75,"low":31.34,"amount":15615.8,"amplitude":0.01268,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.129444,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1756800000000},"marketStatusCode":7,"adr":0,"exchange":"PINK LIMITED","adjPreClose":32.335,"volumeRatio":1.6061007689037088},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BRCTF\",,,,,undefined,":{"symbol":"BRCTF","floatShares":88531500,"roa":"46.25%","roe":"71.96%","lyrEps":0.258365,"volumeRatio":1.6061007689037088,"shares":88531500,"dividePrice":0,"high":31.75,"amplitude":0.01268,"preClose":32.335,"low":31.34,"week52Low":12.9435,"pbRate":"12.82","psRate":"14.04","week52High":32.335,"institutionHeld":0,"latestPrice":31.34,"eps":-0.129444,"divideRate":0,"volume":495,"delay":15,"ttmEps":-0.129444,"open":31.75,"prevYearClose":18.3,"prevWeekClose":31.34,"prevMonthClose":31.34,"prevQuarterClose":19.34,"fiveDayClose":24.796,"twentyDayClose":19.34,"sixtyDayClose":18.74},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BRCTF\",params:#limit:5,,,undefined,":[{"date":"2024-05-17","symbol":"BRCTF","type":"earning","reportTimeType":"","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1715932800000,"name":null,"time":"","dateTimestamp":1715918400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BRCTF\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BRCTF\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.5,"hold":0.1667,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":6,"updateTime":1730779200000},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BRCTF\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2526388195","title":"High Growth Tech Stocks To Watch In Europe April 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2526388195","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526388195?lang=en_us&edition=fundamental","pubTime":"2025-04-09 13:08","pubTimestamp":1744175335,"startTime":"0","endTime":"0","summary":"As European markets grapple with the fallout from higher-than-expected U.S. trade tariffs, which have led to significant declines in major indices like the STOXX Europe 600 and Germany's DAX, investors are keenly observing how these developments might impact high-growth tech stocks in the region. In such volatile conditions, a good stock is often characterized by its ability to demonstrate resilience through innovation and adaptability while maintaining strong fundamentals amidst broader economic uncertainties.OB:CRAYN Earnings and Revenue Growth as at Apr 2025. Overview: BioArctic AB  is a Swedish company focused on developing biological drugs for central nervous system disorders, with a market cap of SEK15.09 billion.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/high-growth-tech-stocks-watch-050855304.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CRAYF","BK4139","HMNTY","BRCTF"],"gpt_icon":0},{"id":"2524219948","title":"The European Commission refers lecanemab decision to Appeal Committee","url":"https://stock-news.laohu8.com/highlight/detail?id=2524219948","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524219948?lang=en_us&edition=fundamental","pubTime":"2025-04-01 18:17","pubTimestamp":1743502620,"startTime":"0","endTime":"0","summary":"STOCKHOLM, April 1, 2025 /PRNewswire/ --BioArctic AB's   partner Eisai today announced that the European Commission  has decided to refer the marketing authorisation approval decision of lecanemab in the EU to the Appeal Committee.If the marketing authorization application for lecanemab is approved, the approval will apply to all 27 European Union member states, as well as Iceland, Liechtenstein, and Norway. Leqembi is already approved in the US, Japan, China, Great Britain and other markets.Lecanemab is approved in the U.S., Japan, China, United Kingdom, and several other markets for the treatment of mild cognitive impairment  due to Alzheimer's disease  and mild AD dementia. Lecanemab's approvals in these countries, as well as the CHMP's positive opinion in November 2024, were primarily based on Phase 3 data from Eisai's global Clarity AD clinical trial, in which it met its primary endpoint and all key secondary endpoints with statistically significant results. Eisai has also submitt","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/european-commission-refers-lecanemab-decision-101700021.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/european-commission-refers-lecanemab-decision-101700021.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4201","BK4215","MCI","BK4087","BK4588","BRCTF","EC","MAA","BK4139","BK4585","CHMP"],"gpt_icon":0},{"id":"2522316327","title":"3 European Growth Stocks With Insider Ownership Seeing Up To 52% Earnings Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2522316327","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522316327?lang=en_us&edition=fundamental","pubTime":"2025-03-27 18:05","pubTimestamp":1743069934,"startTime":"0","endTime":"0","summary":"As European markets experience a mix of modest gains and losses, with the pan-European STOXX Europe 600 Index rising slightly amid hopes for increased government spending, investors are navigating a landscape marked by trade-related uncertainties and inflation concerns. In this environment, stocks with high insider ownership can offer an appealing level of confidence, as insiders often have unique insights into their companies' potential for growth and resilience against economic headwinds.Top 10 Growth Companies With High Insider Ownership In Europe. Pharma Mar exhibits strong growth potential with its earnings forecasted to grow significantly at 40.8% annually, outpacing the Spanish market. Despite a recent decline in sales, net income surged to 26.13 million from 1.14 million year-on-year, indicating high-quality earnings. The company trades at a substantial discount of 47.4% below estimated fair value and maintains a volatile share price but benefits from high insider ownership and","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/3-european-growth-stocks-insider-100534193.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["FBGBY","PHMMF","BRCTF","FBGGF"],"gpt_icon":0},{"id":"2520096935","title":"BioArctic receives Orphan Drug Designation for exidavnemab the US","url":"https://stock-news.laohu8.com/highlight/detail?id=2520096935","media":"PR Newswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520096935?lang=en_us&edition=fundamental","pubTime":"2025-03-18 01:54","pubTimestamp":1742234040,"startTime":"0","endTime":"0","summary":"STOCKHOLM, March 17, 2025 /PRNewswire/ -- BioArctic AB   announced today that the US FDA Office of Orphan Products Development  hasgranted orphan drug designation  to exidavnemab for the treatment of Multiple System Atrophy , providing incentives for the development of treatments for rare diseases with a high medical need.Multiple System Atrophy  is a rapidly progressive and fatal rare disease affecting the central and autonomic nervous systems. MSA is characterized by pathological alpha-synuclein aggregation, that causes gradual damage to nerve cells in the brain. This affects balance, movement and the autonomic nervous system, which controls several basic functions, such as breathing, digestion and bladder control. Currently there is no cure and no available treatment to slow its progression.About MSA Multiple System Atrophy  is a rapidly progressive and fatal rare disease affecting the central and autonomic nervous systems. MSA is a synucleinopathy, a group of neurodegenerative dise","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/bioarctic-receives-orphan-drug-designation-175400532.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bioarctic-receives-orphan-drug-designation-175400532.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MSA","BK4183","LU2125909916.SGD","BRCTF","BK4007","BK4143","LU0757428866.USD","LU2125909759.SGD","ODD","LU0728928796.USD","LU1815336091.USD","LU0053671581.USD","LU2211815571.USD","BIOA","LU1923622291.USD"],"gpt_icon":0},{"id":"2514623324","title":"The Committee for Medicinal Products for Human Use (CHMP) reaffirms positive opinion for Lecanemab in early Alzheimer's disease in the EU","url":"https://stock-news.laohu8.com/highlight/detail?id=2514623324","media":"PR Newswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514623324?lang=en_us&edition=fundamental","pubTime":"2025-02-28 21:12","pubTimestamp":1740748320,"startTime":"0","endTime":"0","summary":"STOCKHOLM, Feb. 28, 2025 /PRNewswire/ -- BioArctic AB's   partner Eisai today announced today that the Committee for Medicinal Products for Human Use  of the European Medicines Agency has reaffirmed its positive opinion for the anti-Aβ monoclonal antibody lecanemab , adopted in November 2024. Following CHMP's reaffirmation, after having considered the additional information requested by the European Commission , the EC will resume the decision-making process for lecanemab's marketing authorisation.If the EC approves the lecanemab marketing authorization application, the approval will apply to all 27 European Union member states, as well as Iceland, Liechtenstein, and Norway. Leqembi is already approved in the US, Japan, China, Great Britain and other markets. Eisai and BioArctic will continue to make every effort to deliver lecanemab to patients with early AD in as soon as possible.Lecanemab is approved in the U.S., Japan, China, United Kingdom, and several other markets for the treatm","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/committee-medicinal-products-human-chmp-131200104.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/committee-medicinal-products-human-chmp-131200104.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4201","BK4139","BK4156","EC","MCI","BK4087","CHMP","BRCTF"],"gpt_icon":0},{"id":"2514034334","title":"High Insider Owned Growth Stocks With Earnings Up To 69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514034334","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514034334?lang=en_us&edition=fundamental","pubTime":"2025-02-25 13:02","pubTimestamp":1740459759,"startTime":"0","endTime":"0","summary":"In the midst of geopolitical tensions and shifting consumer spending patterns, global markets have experienced a volatile week, with major U.S. indexes seeing early gains erased by sharp losses later on. As investors navigate these uncertainties, growth companies with high insider ownership can be particularly appealing due to their potential alignment of interests between company insiders and shareholders, which may provide an added layer of confidence in turbulent times.Top 10 Growth Companies With High Insider Ownership. Overview: BioArctic AB  is a Swedish company focused on developing biological drugs for central nervous system disorders, with a market cap of SEK21.66 billion.Overview: Angelalign Technology Inc. is an investment holding company that focuses on researching, developing, designing, manufacturing, and marketing clear aligner treatment solutions in the People's Republic of China with a market cap of approximately HK$10.84 billion.Angelalign Technology is poised for sig","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/high-insider-owned-growth-stocks-050239194.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BRCTF"],"gpt_icon":0},{"id":"2511630323","title":"BioArctic AB (BRCTF) Q4 2024 Earnings Call Highlights: Strategic Partnerships and Profitability ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2511630323","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511630323?lang=en_us&edition=fundamental","pubTime":"2025-02-14 15:04","pubTimestamp":1739516654,"startTime":"0","endTime":"0","summary":"For the complete transcript of the earnings call, please refer to the full earnings call transcript.BioArctic AB  signed a significant license agreement with Bristol-Myers Squibb, including a $100 million upfront payment and potential milestones totaling $1.25 billion.The company's brain transporter technology has been externally validated, opening up opportunities for further partnerships.Sales of Laambi are increasing, with more patients gaining access to treatment, indicating strong market demand.BioArctic AB  expects to achieve profitability from this year onwards, supported by continuous revenue streams from royalties.The company's pipeline, including the Exidabamab and BT 2,238 programs, is progressing well and receiving interest from external partners.A: We focus on the most developed programs, with costs expected to increase by 50% to 80% in 2025, primarily in R&D. Our priorities include Exidabam, the next-generation Alzheimer's program, and the brain transporter technology. ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bioarctic-ab-brctf-q4-2024-070414921.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AB","BRCTF","BMY"],"gpt_icon":0},{"id":"2510988325","title":"Exploring Three High Growth Tech Stocks For Future Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2510988325","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510988325?lang=en_us&edition=fundamental","pubTime":"2025-02-10 14:02","pubTimestamp":1739167321,"startTime":"0","endTime":"0","summary":"As global markets grapple with trade uncertainties and mixed economic signals, with the S&P 500 showing resilience despite tariff concerns, investors are keenly observing sectors that can weather such volatility. In this context, high-growth tech stocks stand out for their potential to capitalize on innovation and adaptability, making them compelling considerations in today's dynamic market landscape.Click here to see the full list of 1217 stocks from our High Growth Tech and AI Stocks screener.Operations: The company generates revenue primarily through the sale of SD-WAN routers, with mobile-first connectivity contributing HK$59.87 million and fixed-first connectivity a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/exploring-three-high-growth-tech-060201859.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BRCTF","BK4139"],"gpt_icon":0},{"id":"2506343041","title":"Tikehau Capital And 2 More Stocks That May Be Priced Below Their Estimated Worth","url":"https://stock-news.laohu8.com/highlight/detail?id=2506343041","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506343041?lang=en_us&edition=fundamental","pubTime":"2025-01-27 13:02","pubTimestamp":1737954157,"startTime":"0","endTime":"0","summary":"As global markets navigate a landscape marked by political developments and economic shifts, U.S. stocks have surged to record highs, fueled by optimism over trade policies and advancements in artificial intelligence. Amidst this buoyant market environment, identifying stocks that may be undervalued can offer potential opportunities for investors seeking to capitalize on discrepancies between market price and intrinsic value.Tikehau Capital is trading at 21.65, significantly below its estimated fair value of 37.59, highlighting potential undervaluation based on cash flows. Despite a dividend yield of 3.46% not being well covered by free cash flows, the company shows strong growth prospects with earnings expected to rise by 35.9% annually, outpacing the French market's forecasted growth rate of 12%. However, debt coverage by operating cash flow remains a concern for investors.Overview: BioArctic AB  is a Swedish company focused on developing biological drugs for central nervous system d","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/tikehau-capital-2-more-stocks-050237352.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TKKHF","BHLB","BRCTF","BK4139","BK4211"],"gpt_icon":0},{"id":"2506389343","title":"3 Growth Companies Insiders Own With Earnings Growth Up To 51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506389343","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506389343?lang=en_us&edition=fundamental","pubTime":"2025-01-27 13:01","pubTimestamp":1737954103,"startTime":"0","endTime":"0","summary":"As global markets continue to react to political developments and economic indicators, U.S. stocks have been marching toward record highs, buoyed by optimism around softer tariffs and artificial intelligence investments. In this environment of cautious optimism, growth companies with high insider ownership can offer intriguing opportunities for investors, as they often signal confidence in the company's future prospects and alignment between management and shareholders' interests.Top 10 Growth Companies With High Insider Ownership. BioArctic is poised for significant growth, with revenue expected to increase by 41.4% annually, outpacing the market. Despite a volatile share price and no substantial insider buying recently, it trades at 37.5% below fair value estimates. The company has secured a lucrative agreement with Bristol Myers Squibb for its PyroGlu-Ab antibody program, potentially earning up to US$1.25 billion in milestone payments alongside royalties, which could enhance profita","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/3-growth-companies-insiders-own-050143254.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["HMNKF","BRCTF"],"gpt_icon":0},{"id":"2506614311","title":"FDA approves IV maintenance dosing of Leqembi® (lecanemab-irmb) for the treatment of early Alzheimer's Disease in the US","url":"https://stock-news.laohu8.com/highlight/detail?id=2506614311","media":"PR Newswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506614311?lang=en_us&edition=fundamental","pubTime":"2025-01-27 10:53","pubTimestamp":1737946380,"startTime":"0","endTime":"0","summary":"STOCKHOLM, Jan. 27, 2025 /PRNewswire/ -- BioArctic AB   today announced that the U.S. Food and Drug Administration  has approved BioArctic's partner Eisai's Supplemental Biologics License Application  for Leqembi as a once every four weeks intravenous  maintenance dosing. Leqembi is indicated for the treatment of Alzheimer's disease in patients with mild cognitive impairment  or mild dementia stage of disease in the U.S. . This approval means that patients who have completed the biweekly initiation phase of 18 months have the option to transition to a once every four weeks 10 mg/kg dosing regimen.Alzheimer's disease is caused by a continuous underlying neurotoxic process that begins before and continues after plaque removal. Continuous administration of Leqembi is of great value to patients as Leqembi works to fight Alzheimer's Disease in two ways: not only rapidly clearing the amyloid-beta (Aβ) plaque, but it also works to fight the progressive nature of Alzheimer's disease by continu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/fda-approves-iv-maintenance-dosing-025300601.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fda-approves-iv-maintenance-dosing-025300601.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MCI","BK4110","AAIC","BK4087","CHMP","BK4139","BRCTF"],"gpt_icon":0},{"id":"2503599616","title":"FDA accepts Biologics License Application for subcutaneous maintenance dosing of Leqembi® (lecanemab-irmb) in the US","url":"https://stock-news.laohu8.com/highlight/detail?id=2503599616","media":"PR Newswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503599616?lang=en_us&edition=fundamental","pubTime":"2025-01-14 10:51","pubTimestamp":1736823060,"startTime":"0","endTime":"0","summary":"STOCKHOLM, Jan. 14, 2025 /PRNewswire/ --BioArctic AB   today announced that the U.S. Food and Drug Administration  has accepted BioArctic's partner Eisai's Biologics License Application  for Leqembi subcutaneous autoinjector  for weekly maintenance dosingLeqembi is indicated for the treatment of Alzheimer's disease  in patients with Mild Cognitive Impairment  or mild dementia stage of disease . Leqembi is the only FDA-approved anti-amyloid therapy that potentially could offer the convenience of a subcutaneous injection with at-home administration option. The Prescription Drug User Fee Act  action date has been set to August 31, 2025.The BLA is based on data from the Clarity AD  open-label extension  and modeling of observed data. If LEQEMBI subcutaneous maintenance dosing is approved by the FDA, LEQEMBI will be the only treatment for AD that can be administered subcutaneously at home using an autoinjector . The injection process is expected to take, on average, 15 seconds. The SC-AI 36","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/fda-accepts-biologics-license-application-025100211.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fda-accepts-biologics-license-application-025100211.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4087","CHMP","BRCTF","MCI","BK4139"],"gpt_icon":0},{"id":"2502039463","title":"High Growth Tech Stocks To Watch In January 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2502039463","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502039463?lang=en_us&edition=fundamental","pubTime":"2025-01-09 09:02","pubTimestamp":1736384566,"startTime":"0","endTime":"0","summary":"As we enter January 2025, global markets have shown mixed performances with the U.S. stock indices closing out a strong year despite recent fluctuations, while economic indicators such as the Chicago PMI and GDP forecasts suggest caution amid contracting manufacturing activity and revised growth expectations. In this context of varied market sentiment, identifying promising high-growth tech stocks involves focusing on companies that demonstrate resilience and adaptability in navigating economic challenges, as well as those poised to capitalize on technological advancements and innovation.Click here to see the full list of 1253 stocks from our High Growth Tech and AI Stocks screener.Overview: Wemade Co., Ltd. is a company that develops and publishes games both in South Korea and internationally, with a market cap of 1.30 trillion.KOSDAQ:A112040 Earnings and Revenue Growth as at Jan 2025. Overview: BioArctic AB  is a Swedish company focused on developing biological drugs for central nerv","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/high-growth-tech-stocks-watch-010246413.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BRCTF","HMNTY","BK4139"],"gpt_icon":0},{"id":"2492244890","title":"Exploring Undervalued Small Caps With Insider Action In December 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2492244890","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492244890?lang=en_us&edition=fundamental","pubTime":"2024-12-20 19:06","pubTimestamp":1734692807,"startTime":"0","endTime":"0","summary":"As global markets navigate a period of economic uncertainty, small-cap stocks have faced notable challenges, with the Russell 2000 Index underperforming larger counterparts like the S&P 500. Amidst this backdrop, investors are increasingly focused on identifying opportunities within undervalued small-cap companies that may benefit from insider action. In such an environment, a good stock often exhibits resilience and potential for growth despite broader market headwinds, making it crucial to carefully assess financial health and strategic positioning.Click here to see the full list of 194 stocks from our Undervalued Small Caps With Insider Buying screener.Treasure, a small company with limited revenue of US$306K, primarily relies on external borrowing for funding, which carries higher risk compared to customer deposits. Despite its financial structure, the company has shown insider confidence with recent share purchases in 2024, indicating potential future value. Recent board decisions","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/fZxxC7WFAddugsI0.C6IZw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/fZxxC7WFAddugsI0.C6IZw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/exploring-undervalued-small-caps-insider-110647663.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BRCTF","BK4139"],"gpt_icon":0},{"id":"2492933504","title":"Top Growth Stocks With Insider Backing In December 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2492933504","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492933504?lang=en_us&edition=fundamental","pubTime":"2024-12-20 13:01","pubTimestamp":1734670896,"startTime":"0","endTime":"0","summary":"As global markets navigate a period of mixed performances, with the Nasdaq Composite reaching new heights while other indices face declines, investors are keenly observing the Federal Reserve's anticipated rate cut. In this environment, growth stocks with substantial insider ownership can be particularly appealing as they often signal confidence from those closest to the company's operations and potential.Top 10 Growth Companies With High Insider Ownership. Overview: BioArctic AB  is a Swedish company focused on developing biological drugs for central nervous system disorders, with a market cap of SEK19.46 billion.Overview: Lucky Harvest Co., Ltd. operates in China, focusing on the research, development, production, and sale of precision stamping dies and structural metal parts, with a market cap of CN6.73 billion.Operations: The company's revenue segments include precision stamping dies and structural metal parts.Lucky Harvest demonstrates strong growth potential with expected annual ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/q0yRN_h1fYD6SjjSkWx5lg--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4afa9747177650711578ccd57242a6b7","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/q0yRN_h1fYD6SjjSkWx5lg--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4afa9747177650711578ccd57242a6b7"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/top-growth-stocks-insider-backing-050136906.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BRCTF","BK4139"],"gpt_icon":0},{"id":"2492683284","title":"3 Stocks That May Be Trading Below Their Estimated Intrinsic Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2492683284","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492683284?lang=en_us&edition=fundamental","pubTime":"2024-12-20 12:05","pubTimestamp":1734667555,"startTime":"0","endTime":"0","summary":"As global markets navigate a period of economic adjustments and interest rate shifts, investors are keeping a close eye on the Federal Reserve's upcoming decisions and their potential impact on market dynamics. Amidst these fluctuations, identifying stocks that may be trading below their estimated intrinsic value can offer opportunities for long-term growth, especially when broader indices face mixed performance. A good stock in this context is one that demonstrates strong fundamentals and resilience despite current market volatility, providing potential value to investors seeking stability and growth.CLASSYS is trading at 48,800, significantly below its estimated fair value of 67,146.83, suggesting it might be undervalued based on discounted cash flow analysis. The company recently announced a share buyback program worth KRW 25 billion to enhance shareholder value and stabilize stock price. With earnings and revenue expected to grow significantly over the next three years, CLASSYS's f","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/qrnhoA9Y9l_fYJBd0ck5WA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/983f2bdfe32b19227b1d118c45bf4f09","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/qrnhoA9Y9l_fYJBd0ck5WA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/983f2bdfe32b19227b1d118c45bf4f09"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/3-stocks-may-trading-below-040555125.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4588","BK4589","LU0106831901.USD","BK4139","WAL","BRCTF","BK4211","LU1791807156.HKD","LU1668664300.SGD","BK4585"],"gpt_icon":0},{"id":"2492121156","title":"Bristol Myers enters $100M PyroGlu-Ass license agreement with BioArctic","url":"https://stock-news.laohu8.com/highlight/detail?id=2492121156","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492121156?lang=en_us&edition=fundamental","pubTime":"2024-12-19 20:12","pubTimestamp":1734610345,"startTime":"0","endTime":"0","summary":"BioArctic (BRCTF) announced that it has entered into a global exclusive license agreement with Bristol Myers Squibb (BMY) for BioArctic’s PyroGluta...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bristol-myers-enters-100m-pyroglu-ass-license-agreement-with-bioarctic?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bristol-myers-enters-100m-pyroglu-ass-license-agreement-with-bioarctic?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1868837300.USD","IE00BSNM7G36.USD","LU0237698245.USD","LU0321505439.SGD","BK4007","LU0306807586.USD","LU1291159041.SGD","BMY","BK4532","LU0306806265.USD","LU2242646821.SGD","LU1323610961.USD","LU1670711040.USD","LU1989771016.USD","LU2360032135.SGD","BK4588","LU1670710661.SGD","LU0321505868.SGD","LU1868836914.USD","IE00BJT1NW94.SGD","BK4139","BK4585","LU0225284248.USD","IE00BJJMRZ35.SGD","LU1868836757.USD","LU0456855351.SGD","LU0114720955.EUR","LU0882574055.USD","IE0009355771.USD","LU1093756325.SGD","LU1670710588.SGD","LU1670711123.USD","LU1430594728.SGD","IE00B2B36J28.USD","BK4126","BK4559","BK4581","LU2125154935.USD","LU1868837136.USD","LU1571399168.USD","LU1718418525.SGD","BK4534","LU1868836591.USD","BRCTF","IE0002141913.USD","MYE","LU0061475181.USD","LU0985481810.HKD","IE00BFTCPJ56.SGD","LU2242652126.USD"],"gpt_icon":0},{"id":"2490884201","title":"High Growth Tech Stocks To Watch This December 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2490884201","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490884201?lang=en_us&edition=fundamental","pubTime":"2024-12-11 15:05","pubTimestamp":1733900715,"startTime":"0","endTime":"0","summary":"As global markets navigate a mixed landscape, with major U.S. indexes like the S&P 500 and Nasdaq hitting record highs while small-cap indices such as the Russell 2000 face declines, investors are keenly observing how growth stocks are outperforming their value counterparts by a significant margin. In this environment, identifying high-growth tech stocks involves looking for companies that demonstrate strong innovation potential and resilience amid economic shifts, making them compelling to watch in December 2024.Click here to see the full list of 1293 stocks from our High Growth Tech and AI Stocks screener.Overview: Wuxi Taclink Optoelectronics Technology Co., Ltd. operates in the optoelectronics industry and has a market capitalization of CN7.99 billion.Operations: Wuxi Taclink Optoelectronics Technology Co., Ltd. sp","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/89Cy0qSuz7j_kPslCXOpyQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/ea4faffc3f84a9a25b375f33c43cf429","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/89Cy0qSuz7j_kPslCXOpyQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/ea4faffc3f84a9a25b375f33c43cf429"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/high-growth-tech-stocks-watch-070515588.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BRCTF","BK4139"],"gpt_icon":0},{"id":"2484815625","title":"3 Undervalued Small Caps With Insider Buying Across Global Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2484815625","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484815625?lang=en_us&edition=fundamental","pubTime":"2024-11-18 19:08","pubTimestamp":1731928115,"startTime":"0","endTime":"0","summary":"As global markets navigate the uncertainties surrounding the incoming Trump administration and fluctuating economic indicators, small-cap stocks have experienced varied performance, with indices like the S&P 600 reflecting these dynamics. Amid this backdrop, investors often look for opportunities in undervalued small-cap companies that demonstrate potential resilience through insider buying, suggesting confidence in their future prospects.Click here to see the full list of 170 stocks from our Undervalued Small Caps With Insider Buying screener.Operations: Spiltan generates its revenue primarily from unclassified services, with recent figures indicating a negative revenue trend. The company consistently reports a gross profit margin of 100%, suggesting that cost of goods sold is not applicable or minimal. Operating expenses, particularly general and administrative expenses, are notable cost components impacting net income. Recent data shows fluctuations in net income margin, reaching as","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/SSw8naZrBB1tKswm10P8gw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/f88d3d8c5618aa88ce2627c2a1cda340","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/SSw8naZrBB1tKswm10P8gw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/f88d3d8c5618aa88ce2627c2a1cda340"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/3-undervalued-small-caps-insider-110835723.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BRCTF","BK4139"],"gpt_icon":0},{"id":"2484999476","title":"Three Stocks Estimated To Be Undervalued In November 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2484999476","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484999476?lang=en_us&edition=fundamental","pubTime":"2024-11-18 12:06","pubTimestamp":1731902799,"startTime":"0","endTime":"0","summary":"As global markets navigate the uncertainties of the incoming Trump administration and fluctuating interest rate expectations, investors are keenly observing sector-specific impacts such as deregulation in financials and energy, alongside challenges faced by healthcare and electric vehicle sectors. In this environment, identifying undervalued stocks becomes crucial; these are companies whose current market prices may not fully reflect their intrinsic value or future potential amidst shifting economic policies and market dynamics.Click here to see the full list of 935 stocks from our Undervalued Stocks Based On Cash Flows screener.Overview: Range Intelligent Computing Technology Group Company Limited develops data centers and other technology campuses, with a market cap of CN60.22 billion.Range Intelligent Computing Technology Group is trading significantly below its fair value, estimated at CNY 56.06, with a current price of CNY 35. Despite high share price volatility and a dividend not","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/9jcUzKYfUwYqkVFuGwhkDQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4020998fe5d069537fb917fd739e4047","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/9jcUzKYfUwYqkVFuGwhkDQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4020998fe5d069537fb917fd739e4047"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/three-stocks-estimated-undervalued-november-040639474.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BRCTF","BK4139","CSTA.U"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":25,"code":"91000000","status":"200"}]}}